Benjamin Edwards Inc’s Bio-Rad Laboratories Class A BIO Stock Holding History

Benjamin Edwards Inc’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$385K	Buy	1,382 +379	+38%	+$109K	﹤0.01%	1080
2025 Q4	$304K	Buy	1,003 +245	+32%	+$76.5K	﹤0.01%	1106
2025 Q3	$212K	Buy	+758	New	+$206K	﹤0.01%	1231
2022 Q1	–	Sell	-18	Closed	-$14K	–	697
2021 Q4	$14K	Buy	18 +14	+350%	+$10.5K	﹤0.01%	550
2021 Q3	$3K	Buy	+4	New	+$3K	﹤0.01%	496

Other funds holding BIO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Benjamin Edwards Inc's BIO Position: Q1 2026 in Review

Benjamin Edwards Inc increased its Bio-Rad Laboratories Class A (BIO) stake by 38% in Q1 2026, buying an estimated $109K and bringing the position to 1,382 shares worth $385K. The position accounts for ﹤0.01% of the portfolio, ranked #1080.

Benjamin Edwards Inc first reported a position in BIO in Q3 2021 and has held it in 5 quarters since. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

Benjamin Edwards Inc held 1,382 shares of Bio-Rad Laboratories Class A worth $385K as of Q1 2026.
Benjamin Edwards Inc bought 379 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $109K.
Bio-Rad Laboratories Class A made up ﹤0.01% of Benjamin Edwards Inc's portfolio in Q1 2026, its #1080 holding.
Benjamin Edwards Inc first reported a position in Bio-Rad Laboratories Class A in Q3 2021 and has held it in 5 quarters since.
391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Benjamin Edwards Inc's 13F filing for Q1 2026, filed 12 May 2026.